JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Selye, H.
Right arrow Articles by Caruso, P. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Selye, H.
Right arrow Articles by Caruso, P. L.
Journal of Pharmacology And Experimental Therapeutics, Vol. 146, Issue 2, 252-257, 1964
Copyright © 1964 by American Society for Pharmacology and Experimental Therapeutics


TOPICAL RESISTANCE TO MASTOCALCERGY

Hans Selye 1, Beatriz Tuchweber 1, and Pier Luigi Caruso 1

1 Institut de Médecine et de Chirurgie expérimentales, Université de Montréal, Montréal, Canada

Following a brief definition of the new concepts of calcergy and calciphylaxis, experiments are reported which show that, in rats prepared by a single intravenous injection of lead acetate, topical connective tissue calcification can be prduced by minute doses of various mast cell components (histamine, 5-HT) or mast cell dischargers (compound 48/80, polymyxin). This form of calcergy can be inhibited by topical pretreatment with any one among the substances just mentioned. Here, both the production of cutaneous calcinosis and its prevention appear to depend upon compounds that can be liberated by mast cells and, hence, we speak of mastocalcergy.

In rats similarly prepared by an intravenous injection of lead acetate, the subcutaneous injection of formalin or crushing of the skin with a hemostat likewise produces topical calcification. However, this form of calcinosis cannot be prevented by pretreatment with mast cell dischargers, mast cell products, formalin or trauma. Apparently, here we are not dealing with mastocalcergy, but with an essentially different mechanism dependent upon the localization of blood-borne lead and subsequently of calcium salts owing to severe vascular leakage.

Accepted on July 1, 1964




This article has been cited by other articles:


Home page
ScienceHome page
H. Selye
Mast Cells and Necrosis
Science, June 3, 1966; 152(3727): 1371 - 1372.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1964 by the American Society for Pharmacology and Experimental Therapeutics.